How much do paid clinical trials in Fort Collins pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Fort Collins?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

How often do new paid studies open in Fort Collins?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fort Collins.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fort Collins typically complete one or two studies per year.

Paid Clinical Trials Fort Collins, CO — 162 Studies Recruiting (Jul 2026)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought

Rocky Mountain Cancer Centers, LLP — Longmont, Colorado (26.4 mi) · Sponsor: Relay Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought

Advanced Vision Research Institute — Longmont, Colorado (26.4 mi) · Sponsor: Genentech, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT04853251)

The Vanguard Study: Testing a New Way to Screen for Cancer

Bladder Carcinoma, Breast Carcinoma N/A Interventional 24,000 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06995898)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Improving Care for Rural Patients With Solid Tumors

Lung Cancer, Head and Neck Cancer N/A Interventional 320 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: University of Colorado, Denver

See eligibility & contact on ClinicalTrials.gov (NCT04916990)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine Phase 3 Interventional 450 participants sought

Advanced Neurosciences Research, LLC /ID# 247592 — Fort Collins, Colorado (2.8 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT05711394)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

Longmont United Hospital — Longmont, Colorado (26.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought

Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought

Longmont United Hospital — Longmont, Colorado (26.4 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Exactech Shoulder Post Market Clinical Follow-up Study

Osteo Arthritis Shoulders, Osteonecrosis N/A Observational 20,000 participants sought

Orthopaedic and Spine Center of the Rockies — Fort Collins, Colorado (2.8 mi) · Sponsor: Exactech

See eligibility & contact on ClinicalTrials.gov (NCT05603728)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06632977)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: Canadian Cancer Trials Group

See eligibility & contact on ClinicalTrials.gov (NCT06592924)

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Metastatic Breast Cancer Phase 1, Phase 2 Interventional 1,132 participants sought

Rocky Mountain Cancer Center - Longmont — Longmont, Colorado (26.4 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT03424005)

Survivors Uniting for Remote Guided Exercise

Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma) N/A Interventional 300 participants sought

Human Performance Clinical Research Lab — Fort Collins, Colorado (2.8 mi) · Sponsor: Colorado State University

See eligibility & contact on ClinicalTrials.gov (NCT07290309)

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic Arthritis, Axial Spondyloarthritis Phase 1 Interventional 392 participants sought

Pa0019 123 — Fort Collins, Colorado (2.8 mi) · Sponsor: UCB Biopharma SRL

See eligibility & contact on ClinicalTrials.gov (NCT07290036)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought

Longmont United Hospital — Longmont, Colorado (26.4 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Reducing Asthma Attacks in Disadvantaged School Children With Asthma

Asthma in Children N/A Interventional 300 participants sought

Ault-Highland RE-9 school district — Ault, Colorado (17.7 mi) · Sponsor: University of Colorado, Denver

See eligibility & contact on ClinicalTrials.gov (NCT06003569)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought

Longmont United Hospital — Longmont, Colorado (26.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis Phase 3 Interventional 264 participants sought

Advanced Neurosciences Research LLC — Longmont, Colorado (26.4 mi) · Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

See eligibility & contact on ClinicalTrials.gov (NCT06463587)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought

Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04402788)

The Impact of Enhanced Music & Natural Visuals on Emotional Health

Emotion Management Skills, Lifestyle, Healthy N/A Interventional 200 participants sought

Colorado State University — Fort Collins, Colorado (2.8 mi) · Sponsor: soundBrilliance LLC

See eligibility & contact on ClinicalTrials.gov (NCT07676110)

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Inflammatory Breast Carcinoma, Invasive Breast Carcinoma N/A Observational 1,200 participants sought

Banner - MD Anderson Cancer Center - Northern Colorado — Greeley, Colorado (20.6 mi) · Sponsor: M.D. Anderson Cancer Center

See eligibility & contact on ClinicalTrials.gov (NCT00477100)

Paid Clinical Trials in Fort Collins, CO

Studies recruiting near Fort Collins right now

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

The Vanguard Study: Testing a New Way to Screen for Cancer

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Improving Care for Rural Patients With Solid Tumors

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Exactech Shoulder Post Market Clinical Follow-up Study

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Survivors Uniting for Remote Guided Exercise

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Reducing Asthma Attacks in Disadvantaged School Children With Asthma

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

The Impact of Enhanced Music & Natural Visuals on Emotional Health

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Top-rated research centers in Fort Collins

Tekton Research

CSU Human Performance Clinical Research Laboratory

Colorado State University C. Wayne McIlwraith Translational Medicine Institute

CSU Veterinary Diagnostic Laboratories

Wholeness Center

Prati Psychedelic Research and Training Institute

CSU Chemistry Research Building

UCHealth Poudre Valley Hospital : Diabetes Education Wound Healing Center

Care Research

Clinical trials in Fort Collins: what's recruiting

How to enroll in a paid study in Fort Collins

Frequently asked questions

Paid clinical trials near Fort Collins

More of CO

New paid studies open every week